PRODUCTION CYCLE OF CANNABIS
ABOUT CANNATEC. THE
Canntec is part of the Medivie Therapeutic Company which is an Israeli publically traded company. Its previous pharmaceutical experience is developing in the past Laboraide, a birth bite that relieves pain, stress and migraines during childbirth without Medicines. Medivie has signed several agreements with collaborators and investors, among which, Barney’s Farm, Migal and foreign investors.
There are over 60 peer-reviewed research studies examining the benefits of medical marijuana. Sixty-eight percent of these studies found benefit while 8% found no benefit. Twenty-three percent of the studies were inconclusive or neutral. Most research has been conducted on the compound CBD. The benefits of medical marijuana can be attributed to binding to the endocannabinoid system. This has many effects including the treatment of:
- Muscle spasms
- Anxiety and depression
- Multiple sclerosis
- Inflammatory bowel diseases such as Crohn’s disease
The main scope of interest of Medivie is in the field of Pharmaceuticals & Biotechnology, as well as Health care. We operate through our subsidiary, Hi-Pharma, in the medical cannabis plants and products industry.
Hi-Pharma owns approximately 50 acres of agricultural land and a production plant of approximately 1,000 square meters.
Hi-Pharma operates indoor and outdoor cannabis greenhouses in a kibbutz up-north Israel, according to the Israeli Medical Cannabis Good Agricultural Practice (IMC-GAP) regulations.